Condition: Colorectal Adenocarcinoma · Stage I Colorectal Cancer AJCC v8 · Stage II Colorectal Cancer AJCC v8 · Sponsor: M.D. Anderson Cancer Center
This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.
This description comes directly from the study's public registry record.
Arvind Dasari · (713) 792-2828 · adasari@mdanderson.org
Always discuss trial participation with your own doctor first.
| Banner - MD Anderson Cancer Center | Gilbert, Arizona, United States | Terminated |
| Baptist- MD Anderson Cancer Center | Jacksonville, Florida, United States | Terminated |
| The Queen's Medical Center | Honolulu, Hawaii, United States | Terminated |
| St. Luke's Cancer Institute | Boise, Idaho, United States | Terminated |
| Cooper Hospital UNIV MED CTR. | Camden, New Jersey, United States | Terminated |
| UT Southwestern/Simmons Cancer Center-Dallas | Dallas, Texas, United States | Terminated |
| Houston Methodist Cancer Center | Houston, Texas, United States | Terminated |
| M D Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| UT Health San Antonio MD Anderson Cancer Center | San Antonio, Texas, United States | Terminated |
| Baylor Scott & White Research Institute | Temple, Texas, United States | Terminated |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04739072